From: The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy
Follow-up time (months)
Supportive care group (n = 71)
Supportive care plus fluticasone group (n = 71)
p
3
1.5 [-4.4, 11.4]
-1.5[-12.3, 3.4]
0.1
6
2.5 [-7.0, 9.4]
-3.2 [-11.6, 10.9]
0.3
9
0.0 [-12.6, 19.3]
4.5 [-12.3, 23.1]
0.9